Background: Polycystic Ovarian Syndrome (PCOS) is a heterogeneous disorder characterized by chronic hyperandrogenism, anovulation, weight gain, and insulin resistance. Approximately 3.4% of women globally, equivalent to about 116 million individuals, are estimated to be affected by PCOS. Intermittent fasting (IF) is a potential dietary intervention that includes various regimens, such as time-restricted fasting. Aim: The aim of this review article is to explain the complex relationship between polycystic ovarian syndrome and metabolic manifestations, including hyperandrogenism, insulin resistance, obesity, and cardiac dysfunction, and how intermittent fasting helps in treating this syndrome. Method: The method involves an extensive literature search and the extraction of information from various sources. Screening was performed for titles and abstracts, and potentially eligible citations were retrieved by the authors. Results: Intermittent fasting is discussed as a potential approach to improving conditions associated with polycystic ovary syndrome. Various effects of intermittent fasting on polycystic ovarian syndrome are mentioned, such as control of blood glucose levels, reduction of hyperandrogenemia, positive effects on menstrual flow, weight control, and improvement of body composition. Intermittent fasting is reported to reduce insulin resistance and cardiac hypertrophy. Conclusion: More research is required to confirm and establish intermittent fasting as a recommended treatment for polycystic ovarian syndrome. The absence of studies on the impact of intermittent fasting on the metabolic syndrome of polycystic ovarian syndrome patients is highlighted, indicating the need for further research.